Latest News

Updates on our progress, publications, and company announcements.

January 27, 2026

EngramBio Named Winner of the 2025 NIH NIA Startup Challenge

We are honored to be recognized as winners of the NIA Startup Challenge by the NIH for our innovative approach to healthy aging and neuroscience.

January 22, 2026

New Publication in Molecular Neurodegeneration: Tau Oligomers Induced Synapse Decline in Human iPSC-Derived Neurons

Our latest research co-authored by our founders show that tau oligomers trigger progressive synapse decline and deterioration in human iPSC-derived neurons.

September 4, 2025

EngramBio Named NIH NIA Startup Challenge Finalist

We are honored to be recognized by the NIH for our innovative approach to healthy aging and neuroscience.

February 1, 2024

New Publication in Journal of Clinical Investigation: KIBRA and Memory Restoration

Our latest research co-authored by our founders detailing synaptic repair mechanisms.

EngramBio

A science-driven biotech startup developing therapeutics to treat and reverse neurodegenerative diseases, integrating experimental biology with modern computational tools.

Location

Moraga, CA


© 2026 EngramBio. All rights reserved.